Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer
- 30 September 2005
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 98 (3) , 383-389
- https://doi.org/10.1016/j.ygyno.2005.04.024
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situBritish Journal of Cancer, 2004
- Cyclooxygenase‐2 expression in endometrial carcinomaCancer, 2002
- Nuclear DNA content, proliferative activity, and p53 expression related to clinical and histopathologic features in endometrial carcinomaInternational Journal of Gynecologic Cancer, 2002
- INHIBITION OF CYCLOOXYGENASE-2 SUPPRESSES ANGIOGENESIS AND THE GROWTH OF PROSTATE CANCER IN VIVOJournal of Urology, 2000
- Is cyclooxygenase-2 the alpha and the omega in cancer?Journal of Clinical Investigation, 2000
- Regulation of Cyclooxygenase-2 pathway by HER2 receptorOncogene, 1999
- Cancer statistics, 1996CA: A Cancer Journal for Clinicians, 1996
- Heterogeneity in hormone receptor status in primary and metastatic endometrial cancerGynecologic Oncology, 1990
- Oestrogen and Progestin Receptors as Prognostic Indicators in Endometrial Cancer: A review of the literatureActa Oncologica, 1989
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958